← All Sponsors
SPONSOR

University Health Network, Toronto

Total Trials
29
Recruiting
29
Phases
Phase 2, Phase 3, Phase 2, Phase 3, Phase 4, Phase 1

University Health Network, Toronto is a clinical research sponsor with 29 registered studies on ClinicalTrials.gov, of which 29 are actively recruiting participants. Research covers conditions including Point-of-care Ultrasound, Metastatic Cancer, Palliative, Major Depressive Disorder.

The trial portfolio spans Phase 2, Phase 3, Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — University Health Network, Toronto

How many clinical trials has University Health Network, Toronto sponsored?
ClinicalMetric currently tracks 29 clinical trials sponsored by University Health Network, Toronto, of which 29 are actively recruiting participants. These trials cover conditions including Point-of-care Ultrasound, Metastatic Cancer, Palliative. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University Health Network, Toronto research focus on?
University Health Network, Toronto clinical trials span Point-of-care Ultrasound, Metastatic Cancer, Palliative, Major Depressive Disorder, Suicide, and additional conditions. The research pipeline includes Phase 2, Phase 3, Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University Health Network, Toronto clinical trial?
To participate in a University Health Network, Toronto trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University Health Network, Toronto trials with current recruitment status updated daily.

Clinical Trials by University Health Network, Toronto

NCT07580456
Recruiting

AI for Gastric POCUS ( Point-of-care Ultrasound)

Point-of-care Ultrasound
NCT04983199
Recruiting

Patient Reported Outcomes/Metrics Program Trial

Metastatic Cancer
NCT06480500 Phase 2
Recruiting

i-CBT and IV Ketamine for Suicidality in Treatment-Resistant Depression: A Randomized, Midazolam-Controlled Clinical Trial

Major Depressive Disorder
NCT06508567
Recruiting

Salvage MR-guided High-Dose-Rate Brachytherapy for Prostate Bed Recurrence After Radiotherapy in the PSMA PET Scan Era

Prostate Cancer Recurrent
NCT05403177
Recruiting

Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)

Breast Cancer
NCT07696741
Recruiting

PRT for Chronic Low Back Pain

Chronic Low Back Pain (CLBP)
NCT07048743 Phase 2
Recruiting

Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Caregivers of Patients With Advanced Cancer

Caregiver Distress
NCT07240558 Phase 3
Recruiting

Pandemic Influenza Vaccine in Organ Transplantation (PIVOT Trial)

Influenza (Pandemic)
NCT05517434 Phase 2, Phase 3
Recruiting

Autologous BMA vs Saline and LAM + LP-PRP vs Saline Evaluations in Knee OA

Osteoarthritis, Knee
NCT05074355 Phase 2
Recruiting

Study of Venetoclax and Azacitidine in Advanced BCR-ABL Negative Myeloproliferative Neoplasms

Myeloproliferative Neoplasm
NCT06487403
Recruiting

HN-BIO 02: A Phase II Randomized Study of the Effects of Delayed Elective Radiotherapy on Head and Neck MRI and Immune Response Biomarkers

Squamous Cell Carcinoma of Head and Neck
NCT05989477
Recruiting

At-home Breast Oncology Care Delivered With E-health Solutions

Patient Engagement
NCT07348887
Recruiting

Phase II Study of Daily Adaptive Radiotherapy for Submandibular Gland-sparing in Head and Neck Cancer

Squamous Cell Cancer of Head and Neck (SCCHN)
NCT06726642
Recruiting

CfDNA in Hereditary And High-risk Malignancies 2

Hereditary Cancer Syndrome
NCT06193369
Recruiting

Digital Peer Navigation for Adolescents and Young Adults With Cancer

Lymphoma
NCT06384456 Phase 4
Recruiting

Topical TRanexamic Acid vs. Placebo on Acute Postoperative Pain Following DRF Fixation

Distal Radius Fractures
NCT03667027
Recruiting

Diaphragm Structure and Pathobiology in Patients Being Bridged to Lung Transplant

Diaphragm Injury
NCT03675386
Recruiting

Reducing Opioid Use for Chronic Pain Patients Following Surgery

Chronic Pain
NCT06142773
Recruiting

Study to Investigate an Association Between Brain Activity and Tidal Volume in Humans (BATMAN)

Ventilation Therapy; Complications
NCT02811523 Phase 1
Recruiting

In Vivo Lung Perfusion for Pulmonary Metastases of Sarcoma

Bone Sarcoma
NCT02678884
Recruiting

Head and Neck Squamous Cell Carcinoma (HNSCC)PET-CT Pilot Study

Head and Neck Squamous Cell Carcinoma
NCT03153670
Recruiting

3T MRI in Patients With Deep Brain Stimulation (DBS)

Neuro-Degenerative Disease
NCT06216470 Phase 2
Recruiting

Vaccinal Effect of HBsAg Monoclonal Ab VIR-3434 in Chronic Hepatitis B Infection [VISION]

Hepatitis B, Chronic
NCT07628751
Recruiting

A Study of Standard Of Care Versus Radio Ablation in Early Stage HCC

Early Hepatocellular Carcinoma
NCT07055243 Phase 2
Recruiting

To Assess Safety of Mitapivat and Provide Proof of Concept of the Efficacy of the Drug in Patients With RBC Membranopathies or CDAII.

Anemia
NCT06381453 Phase 2
Recruiting

Belimumab in Autoimmune Hepatitis

Autoimmune Hepatitis
NCT03218332
Recruiting

Post-Concussion Syndrome in Professional Athletes: A Multidisciplinary Study

Chronic Traumatic Encephalopathy
NCT06620601
Recruiting

Digital Technology for Sleep and Homelessness

Sleep Apnea
NCT04646707
Recruiting

Effect of Erector Spinae (ESP) Block on Opioid Reduction and Enhanced Recovery After Posterior Cervical Spine Surgery

Postoperative
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology